Trastuzumab in CNS progressive metastatic breast cancer.
Alicia
A
Tosoni
Enrico
E
Franceschi
Roberta Degli
RD
Esposti
Alba A
AA
Brandes
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D002490:Central Nervous System / Q000187:drug effects; D005260:Female; D018734:Genes, erbB-2 / Q000187:drug effects; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy; D011379:Prognosis; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab